Track topics on Twitter Track topics that are important to you
17008-90th AvenueSuite #607
Fax: (888) 442-5999
DUBLIN, Jan. 24, 2018 /PRNewswire/ -- The "Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, S...
The FDA recently approved expanding the indication for Ferring’s subcutaneous somatropin 5 mg and 10 mg recombinant human growth hormone to include replacement of growth hormone in adults with growt...
Global Human Growth Hormone (hGH) Market Analysis and Forecasts 2014-2017 & 2025: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SGA – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SG...
Ferring Pharmaceuticals has been awarded US FDA approval for its Zomacton recombinant human growth hormone…
Ferring today announced that the FDA has approved ZOMACTON for Injection 5 mg and 10 mg recombinant human growth hormone indicated for replacement of GH in adults with GH deficiency.
What does the current data tell us about the long-term safety of recombinant human growth hormone treatment? Clinical Endocrinology
COPENHAGEN, Denmark, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet...
The FDA approved Ferring's Zomacton, or somatropin [rDNA origin], injection for the replacement of growth hormone in adult pa -More-
Saizen [somatropin (rDNA origin) for injection] For subcutaneous or intramuscular injection
DESMOPRESSIN ACETATE TABLETS, 0.1 mg and 0.2 mg
Zorbtive [somatropin (rDNA origin) for injection]
Octreotide Acetate Injection
Octreotide Acetate Injection
The pre-treatment characteristics and evaluation of the effects of recombinant human growth hormone therapy in children with growth hormone deficiency and celiac disease or inflammatory bowel disease.
was to investigate the coincidence of growth hormone deficiency (GHD) and celiac disease (CD) or inflammatory bowel disease (IBD) in patients referred for short stature, and to evaluate the baseline a...
Numerous reports on the interactions between the immune and endocrine systems, especially growth hormone axis, can be found in the literature. Growth hormone acts mainly indirectly through insulin-lik...
Reports on the association between growth hormone deficiency (GHD) and cardiovascular risk factors in children are limited. We aim to investigate the effect of different doses of rhGH therapy on blood...
Data about the impact of growth hormone treatment (GHT) on insulin sensitivity in children are quite controversial, due to the different surrogate indices that have been used.
A six month study of ACP-001, a long-acting growth hormone product, versus standard human growth hormone therapy. ACP-001 will be given once-a-week, standard human growth hormone (hGH) wil...
This study will investigate whether growth hormone, administered in a physiological or pulsatile (pulse-like) fashion, can elicit relevant changes in the human immune system while at the s...
The purpose of this study is to investigate the effect of low-dose human growth hormone therapy on immune status and fat morphology.
The protein polymorphism of the growth hormone receptor characterized by the genomic deletion of exon 3 has been linked to the magnitude of the first-year-growth response to growth hormone...
Circulating concentrations of cytokines, such as leptin, tumor necrosis factor-alpha and interleukins 1 and 6 are increased in patients with chronic kidney disease (CKD). In light of the i...
BresaGen is based in Adelaide, South Australiaand operates a cGMP facility with the capacity to manufacture recombinant proteins and peptides. The Company has human therapeutic API candidates and offe...
Genexine, Inc., listed on KOSDAQ (095700) since 2009, is a leading biotherapeutics company focused on immuno-oncology and orphan disease. Genexine has robust pipelines in clinical...
Globe Labs manufactures and sells high quality, low cost human therapeutic proteins, human growth hormones, enzymes, research laboratory cytokines, chemokines & their respective inhibitors/antagonists...
Trophogen, Inc. is a biotechnology company founded in 2001 with series A funding from Toucan Capital, focusing on the development of high affinity glycoprotein hormone and related growth factor analog...
We have published hundreds of HGH Human Growth Hormone news stories on BioPortfolio along with dozens of HGH Human Growth Hormone Clinical Trials and PubMed Articles about HGH Human Growth Hormone for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HGH Human Growth Hormone Companies in our database. You can also find out about relevant HGH Human Growth Hormone Drugs and Medications on this site too.